Cited 1 time in
Human acyl-CoA: Cholesterol acyltransferase (hACAT) inhibitory activities of triterpenoids from roots of Glycine max (L.) Merr.
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Jin Hwan | - |
| dc.contributor.author | Ryu, Young Bae | - |
| dc.contributor.author | Lee, Byong Won | - |
| dc.contributor.author | Kim, Jin Hyo | - |
| dc.contributor.author | Lee, Woo Song | - |
| dc.contributor.author | Park, Yong-Dae | - |
| dc.contributor.author | Jeong, Tae-Sook | - |
| dc.contributor.author | Park, Ki Hun | - |
| dc.date.accessioned | 2022-12-27T06:11:11Z | - |
| dc.date.available | 2022-12-27T06:11:11Z | - |
| dc.date.issued | 2008-03-20 | - |
| dc.identifier.issn | 0253-2964 | - |
| dc.identifier.issn | 1229-5949 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/27464 | - |
| dc.description.abstract | Eight triterpenoids, six lanostanes 1-6, one lupenane 7, and one oleanane 8, were isolated by bioactivity-guided fractionation of the ethylacetate extract from roots of Glycine max (L.) Merr. All isolated compounds were examined for their inhibitory activities against human ACAT-1 (hACAT-1) and human ACAT-2 (hACAT-2). Among them, three triterpenoids showed potent hACAT inhibitory activities, (24R)-ethylcholest-5-ene-3,7-diol (1) and 3 beta-hydroxylup-20(29)-en-28-oic acid (7) exhibited more potent inhibitory activity against hACAT-1 (1: IC50 = 25.0 +/- 1.2 and 7: IC50 = 11.5 +/- 0.4 mu M) than hACAT-2 (1: IC50 = 102.0 +/- 5.4 and 7: IC50 = 33.9 +/- 3.7 mu M), respectively. Interestingly, 5 alpha,8 alpha-epidioxy-24(R)-methylcholesta-6,22-diene-3 beta-ol (4) has proven to be a specific inhibitor against hACAT-1 (IC50 = 38.7 +/- 0.8 mu M) compared to hACAT-2 (IC50 > 200). In conclusion, this is the first study to demonstrate that triterpenoids of G. max have potent inhibitory activities against hACAT-1 and hACAT-2. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | WILEY-V C H VERLAG GMBH | - |
| dc.title | Human acyl-CoA: Cholesterol acyltransferase (hACAT) inhibitory activities of triterpenoids from roots of Glycine max (L.) Merr. | - |
| dc.type | Article | - |
| dc.publisher.location | 독일 | - |
| dc.identifier.doi | 10.1002/bem.20427 | - |
| dc.identifier.scopusid | 2-s2.0-41549149089 | - |
| dc.identifier.wosid | 000255229900019 | - |
| dc.identifier.bibliographicCitation | BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.29, no.3, pp 615 - 619 | - |
| dc.citation.title | BULLETIN OF THE KOREAN CHEMICAL SOCIETY | - |
| dc.citation.volume | 29 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 615 | - |
| dc.citation.endPage | 619 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART001238490 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
| dc.subject.keywordPlus | ANTIOXIDANT ACTIVITY | - |
| dc.subject.keywordPlus | SOYBEAN ISOFLAVONES | - |
| dc.subject.keywordPlus | ERGOSTEROL PEROXIDE | - |
| dc.subject.keywordPlus | HUMAN ACAT-1 | - |
| dc.subject.keywordPlus | COENZYME | - |
| dc.subject.keywordPlus | COMPONENTS | - |
| dc.subject.keywordAuthor | Glycine max | - |
| dc.subject.keywordAuthor | root | - |
| dc.subject.keywordAuthor | human acyl-CoA : holesterol acytransferase (hACAT) | - |
| dc.subject.keywordAuthor | triterpenoid | - |
| dc.subject.keywordAuthor | atherosclerosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
